Nakao, K., Kobuchi, S., Marutani, S., Iwazaki, A., Tamiya, A., Isa, S., . . . Atagi, S. (2019). Population pharmacokinetics of afatinib and exposure-safety relationships in Japanese patients with EGFR mutation-positive non-small cell lung cancer. Sci Rep.
Style de citation ChicagoNakao, Keiko, et al. "Population Pharmacokinetics of Afatinib and Exposure-safety Relationships in Japanese Patients With EGFR Mutation-positive Non-small Cell Lung Cancer." Sci Rep 2019.
Style de citation MLANakao, Keiko, et al. "Population Pharmacokinetics of Afatinib and Exposure-safety Relationships in Japanese Patients With EGFR Mutation-positive Non-small Cell Lung Cancer." Sci Rep 2019.
Attention : ces citations peuvent ne pas être correctes à 100%.